Authors:
van Es, RJJ
Nijsen, JFW
Dullens, HFJ
Kicken, M
van der Bilt, A
Hennink, W
Koole, R
Slootweg, PJ
Citation: Rjj. Van Es et al., Tumour embolization of the Vx2 rabbit head and neck cancer model with Dextran hydrogel and Holmium-poly(L-lactic acid) microspheres: a radionuclide and histological pilot study, J CRAN MAX, 29(5), 2001, pp. 289-297
Authors:
van Es, RJJ
Nijsen, JFW
van het Schip, AD
Dullens, HFJ
Slootweg, PJ
Koole, R
Citation: Rjj. Van Es et al., Intra-arterial embolization of head-and-neck cancer with radioactive holmium-166 poly(L-lactic acid) microspheres: an experimental study in rabbits, INT J OR M, 30(5), 2001, pp. 407-413
Authors:
Verhoeven, JW
Cune, MS
Van Kampen, FMC
Koole, R
Citation: Jw. Verhoeven et al., The use of the transmandibular implant system in extreme atrophy of the mandible; a retrospective study of the results in two different hospital situations, J ORAL REH, 28(6), 2001, pp. 497-506
Authors:
van Es, RJJ
Dullens, HFJ
van der Bilt, A
Koole, R
Slootweg, PJ
Citation: Rjj. Van Es et al., Evaluation of the VX2 rabbit auricle carcinoma as a model for head and neck cancer in humans, J CRAN MAX, 28(5), 2000, pp. 300-307
Authors:
Van Es, RJJ
Baselmans, AHC
Koten, JW
Van Dijk, JE
Koole, R
Den Otter, W
Citation: Rjj. Van Es et al., Perilesional IL-2 treatment of a VX2 head-and-neck cancer model can inducea systemic anti-tumour activity, ANTICANC R, 20(6B), 2000, pp. 4163-4170
Authors:
Stokkel, MPM
ten Broek, FW
Hordijk, GJ
Koole, R
van Rijk, PP
Citation: Mpm. Stokkel et al., Preoperative evaluation of patients with primary head and neck cancer using dual-head (18)fluorodeoxyglucose positron emission tomography, ANN SURG, 231(2), 2000, pp. 229-234
Citation: Rs. Katz et R. Koole, Special Issue: Political Data Yearbook, 1999 (1 January 1998-1 January 1999) - Political data in 1998, EUR J POL R, 36(3-4), 1999, pp. 307-315
Authors:
Kropveld, A
Rozemuller, EH
Leppers, FGJ
Scheidel, KC
de Weger, RA
Koole, R
Hordijk, GJ
Slootweg, PJ
Tilanus, MGJ
Citation: A. Kropveld et al., Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers, LAB INV, 79(3), 1999, pp. 347-353